TREATMENT OF MULTIPLE-MYELOMA WITH AN INTENSIVE 5-DRUG COMBINATION OR INTERMITTENT MELPHALAN AND PREDNISONE - A RANDOMIZED MULTICENTER TRIAL

被引：0

作者：

PALVA, IP

AHRENBERG, P

ALAHARJA, K

ALMQVIST, A

APAJALAHTI, J

HALLMAN, H

HANNINEN, A

ILVONEN, M

ISOMAA, B

JARVENPAA, E

JARVENTIE, G

KILPI, H

KOISTINEN, S

KORPI, E

KOIVUNEN, E

KATKA, K

LAHTINEN, R

LAITINEN, A

LEHTINEN, M

MAKELA, H

NYLANDEN, P

OIVANEN, T

PELLINIEMI, TT

PULLI, T

RAJAMAKI, A

ROSENGARD, S

TIMONEN, T

WARIS, E

WASASTJERNA, C

VILPO, J

机构：

[1] CENT HOSP VAASA,VAASA,FINLAND

[2] DIST HOSP AHTARI,AHTARI,FINLAND

[3] DIST HOSP PIETARSAARI,PIETARSAARI,FINLAND

[4] CENT HOSP LAPPEENRANTA,LAPPEENRANTA,FINLAND

[5] CENT HOSP MIKKELI,MIKKELI,FINLAND

[6] CENT HOSP PORI,PORI,FINLAND

[7] CENT HOSP ROVANIEMI,RAVANIEMI,FINLAND

[8] CENT HOSP SAVONLINNA,SAVONLINNA,FINLAND

[9] CENT HOSP SEINAJOKI,SEINAJOKI,FINLAND

[10] UNIV HOSP KUOPIO,KUOPIO,FINLAND

[11] UNIV HOSP OULU,OULU,FINLAND

[12] UNIV HOSP TAMPERE,TAMPERE,FINLAND

[13] UNIV HOSP TURKU,TURKU,FINLAND

[14] CENT HOSP JOENSUU,JOENSUU,FINLAND

[15] CENT HOSP KAJAANI,KAJAANI,FINLAND

[16] CENT HOSP KEMI,KEMI,FINLAND

[17] CENT HOSP KOKKOLA,KOKKOLA,FINLAND

来源：

EUROPEAN JOURNAL OF HAEMATOLOGY | 1987年 / 38卷 / 01期

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：50 / 54

页数：5

共 50 条

[41] Bortezomib-Melphalan-Prednisone-Thalidomide Followed by Maintenance With Bortezomib-Thalidomide Compared With Bortezomib-Melphalan-Prednisone for Initial Treatment of Multiple Myeloma: A Randomized Controlled Trial
Palumbo, Antonio
Bringhen, Sara
Rossi, Davide
Cavalli, Maide
Larocca, Alessandra
Ria, Roberto
Offidani, Massimo
Patriarca, Francesca
Nozzoli, Chiara
Guglielmelli, Tommasina
Benevolo, Giulia
Callea, Vincenzo
Baldini, Luca
Morabito, Fortunato
Grasso, Mariella
Leonardi, Giovanna
Rizzo, Manuela
Falcone, Antonietta Pia
Gottardi, Daniela
Montefusco, Vittorio
Musto, Pellegrino
Petrucci, Maria Teresa
Ciccone, Giovannino
Boccadoro, Mario
[J]. JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (34) : 5101 - 5109
[42] INITIAL VERSUS DEFERRED MELPHALAN-PREDNISONE THERAPY FOR ASYMPTOMATIC MULTIPLE-MYELOMA STAGE-I - A RANDOMIZED STUDY
HJORTH, M
HELLQUIST, L
HOLMBERG, E
MAGNUSSON, B
RODJER, S
WESTIN, J
[J]. EUROPEAN JOURNAL OF HAEMATOLOGY, 1993, 50 (02) : 95 - 102
[43] MULTIPLE-MYELOMA WITH HIGH TUMORAL MASS - COMBINED TREATMENT WITH MELPHALAN, CYCLOPHOSPHAMIDE, VINCRISTINE, CCNU AND PREDNISONE - 35 CASES
BRUN, B
KUENTZ, M
MAN, NG
FEUILHADE, F
BIERLING, P
VERNANT, JP
FARCET, JP
CORDONNIER, C
REYES, F
DREYFUS, B
ROCHANT, H
[J]. PRESSE MEDICALE, 1983, 12 (19): : 1205 - 1210
[44] A randomized trial with melphalan and prednisone versus melphalan and prednisone plus thalidomide in newly diagnosed multiple myeloma patients not eligible for autologous stem cell transplant
Sacchi, Stefano
Marcheselli, Raffaella
Lazzaro, Antonio
Morabito, Fortunato
Fragasso, Alberto
Di Renzo, Nicola
Balleari, Enrico
Neri, Santo
Quarta, Giovanni
Ferrara, Raimondo
Vigliotti, Maria Luigia
Polimeno, Giuseppe
Musto, Pellegrino
Consoli, Ugo
Zoboli, Alessandra
Buda, Gabriele
Pastorini, Alessandro
Masini, Luciano
[J]. LEUKEMIA & LYMPHOMA, 2011, 52 (10) : 1942 - 1948
[45] ORAL MELPHALAN, PREDNISONE AND THALIDOMIDE IN ELDERLY MULTIPLE MYELOMA PATIENTS: UPDATED RESULTS OF A RANDOMIZED CONTROLLED TRIAL
Palumbo, A.
Bringhen, S.
Liberati, A. M.
Caravita, T.
Falcone, A.
Callea, V.
Cangialosi, C.
Grasso, M.
Galli, M.
Rossini, F.
Catalano, L.
De Stefano, V.
Morandi, S.
Petrucci, M. T.
Falco, P.
Larocca, A.
Magarotto, V.
Ciccone, G.
Cavo, M.
Boccadoro, M.
[J]. HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2008, 93 : 364 - 365
[46] A randomized multicenter study of bendamustine/prednisone versus melphalane/prednisone in the primary treatment of multiple myeloma.
Pönisch, W
Mitrou, PS
Merkle, KM
Rieth, A
Herold, M
Schulze, A
Bittrich, A
Assmann, M
Schirmer, V
Wilhelm, G
Dachselt, K
Richter, P
Subert, R
Friedrich, T
Helbig, W
Niederwieser, D
[J]. BLOOD, 1999, 94 (10) : 123A - 123A
[47] Oral melphalan, prednisone, and thalidomide in elderly patients with multiple myeloma: updated results of a randomized controlled trial
Palumbo, Antonio
Bringhen, Sara
Liberati, Anna M.
Caravita, Tommaso
Falcone, Antonietta
Callea, Vincenzo
Montanaro, Marco
Ria, Roberto
Capaldi, Antonio
Zambello, Renato
Benevolo, Giulia
Derudas, Daniele
Dore, Fausto
Cavallo, Federica
Gay, Francesca
Falco, Patrizia
Ciccone, Giovannino
Musto, Pellegrino
Cavo, Michele
Boccadoro, Mario
[J]. BLOOD, 2008, 112 (08) : 3107 - 3114
[48] Melphalan, prednisone, thalidomide and defibrotide in relapsed/refractory multiple myeloma: results of a multicenter phase I/II trial
Palumbo, Antonio
Larocca, Alessandra
Genuardi, Mariella
Kotwica, Katarzyna
Gay, Francesca
Rossi, Davide
Benevolo, Giulia
Magarotto, Valeria
Cavallo, Federica
Bringhen, Sara
Rus, Cecilia
Masini, Luciano
Iacobelli, Massimo
Gaidano, Gianluca
Mitsiades, Constantine
Anderson, Kenneth
Boccadoro, Mario
Richardson, Paul
[J]. HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2010, 95 (07): : 1144 - 1149
[49] A phase I/II trial on melphalan, prednisone, thalidomide and defribotide combination in relapsed/refractory multiple myeloma patients
Palumbo, Antonio
Larocca, Alessandra
Rus, Cecilia
Gay, Francesca
Rossi, Davide
Pregno, Patrizia
Falco, Patrizia
Avonto, Ilaria
Magarotto, Valeria
Cavallo, Federica
Iacobelli, Massimo
Gaidano, Gianluca
Mitsiades, Constantine
Richardson, Paul G.
Anderson, Kenneth C.
Boccadoro, Mario
[J]. BLOOD, 2007, 110 (11) : 797A - 797A
[50] ASSESSMENT OF MELPHALAN AND PREDNISONE (MP) VERSUS THE SAME DRUGS PLUS CYCLOPHOSPHAMIDE, MECCNU AND VINCRISTINE (MPCCV) IN THE TREATMENT OF MULTIPLE-MYELOMA
PAVLOVSKY, S
SASLAVSKY, J
PINTO, MT
CAVAGNARO, F
CURUTCHET, M
LEIN, JM
GARAY, G
DRAGOSKY, M
BERGNA, L
[J]. PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1981, 22 (MAR): : 536 - 536

← 1 2 3 4 5 →